Skip to main content
Younbok Lee

Dr Younbok Lee PhD

Senior Lecturer

Research interests

  • Neuroscience

Contact details

Biography

Gene therapy is a powerful and innovative approach for patients using molecular biology tools to engineer genetic materials. This revolutionary therapy holds promise for treating a wide range of diseases, from rare genetic disorders to neurodegenerative diseases. Our team is developing gene therapy trials for FTD/ALS and multiple types of gene therapy vectors and delivery strategies. We are also involved in regulatory and operational challenges of gene therapy trials, including early discovery, vector science, and pre-clinical studies. We have a strong Industry partnership with King’s College London spinout company AviadoBio. As I am a co-founder of the AviadoBio (vice president and Head of discovery), our lab is developing transformative medicines with industry partners for patients with debilitating and life-threatening neurodegenerative disorders.

Please see my Research Staff Profile for more detail.

 

Key Publications:

View all publications

Key collaborators:

  • Professor Amit Nathwani, University College London
  • Professor Jernej Ule, University College London
  • Professor Christopher Shaw, King's College London
  • Professor James Uney, University of Bristol

News

King's spinout to develop ground-breaking neurodegenerative gene therapy

AviadoBio is an exciting new spin-out company founded by King’s College London researchers Professor Christopher Shaw, Dr Youn Bok Lee and Dr Do Young Lee

Chris Shaw brain

News

King's spinout to develop ground-breaking neurodegenerative gene therapy

AviadoBio is an exciting new spin-out company founded by King’s College London researchers Professor Christopher Shaw, Dr Youn Bok Lee and Dr Do Young Lee

Chris Shaw brain